Literature DB >> 19787858

Impact of aging on cancer immunity and immunotherapy.

Graham Pawelec, Joseph Lustgarten, Carl Ruby, Claudia Gravekamp.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19787858     DOI： 10.1007/s00262-009-0743-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  8 in total

1.  Progressive ossification of the bone marrow vasculature with advancing age corresponds with reduced red blood cell count and percentage of circulating lymphocytes in male Fischer-344 rats.

Authors:  Sophie Guderian; Seungyong Lee; Mary Ann McLane; Rhonda D Prisby
Journal:  Microcirculation       Date:  2019-06-17       Impact factor: 2.628

Review 2.  Aging, nutrient signaling, hematopoietic senescence, and cancer.

Authors:  Priya Balasubramanian; Valter D Longo
Journal:  Crit Rev Oncog       Date:  2013

3.  Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

Authors:  Marie L Huber; Laura Haynes; Chris Parker; Peter Iversen
Journal:  J Natl Cancer Inst       Date:  2012-01-09       Impact factor: 13.506

4.  Aging, cancer, and cancer vaccines.

Authors:  Paolo Mazzola; Saba Radhi; Leonardo Mirandola; Giorgio Annoni; Marjorie Jenkins; Everardo Cobos; Maurizio Chiriva-Internati
Journal:  Immun Ageing       Date:  2012-04-17       Impact factor: 6.400

Review 5.  mTOR and Aging: An Old Fashioned Dress.

Authors:  Giovanni Stallone; Barbara Infante; Concetta Prisciandaro; Giuseppe Grandaliano
Journal:  Int J Mol Sci       Date:  2019-06-06       Impact factor: 5.923

6.  Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer.

Authors:  Takeshi Masuda; Kazunori Fujitaka; Nobuhisa Ishikawa; Kikuo Nakano; Masahiro Yamasaki; Souichi Kitaguchi; Ken Masuda; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Yasushi Horimasu; Shigeo Kawase; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Naoki Shiota; Tadashi Senoo; Yoshikazu Awaya; Tomohiro Kondo; Takashi Yoshida; Hironobu Hamada; Isao Murakami; Noboru Hattori
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

7.  Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.

Authors:  Jithendra Kini Bailur; Evelyna Derhovanessian; Brigitte Gueckel; Graham Pawelec
Journal:  J Immunother Cancer       Date:  2015-10-20       Impact factor: 13.751

Review 8.  Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix.

Authors:  Mark Owyong; Gizem Efe; Michael Owyong; Aamna J Abbasi; Vaishnavi Sitarama; Vicki Plaks
Journal:  Front Cell Dev Biol       Date:  2018-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.